NCT00053599

Data

{
  "briefSummary": "CLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD). Statins are commonly used to treat high cholesterol levels, which increase the risk of heart disease and stroke.",
  "completionDate": "2007-10",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 400,
  "enrollmentType": null,
  "nctId": "NCT00053599",
  "phase": "PHASE3",
  "sponsorId": "national-institute-on-aging-nia",
  "startDate": "2002-12",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00053599"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version